What's Happening?
The Department of Commerce in India organized a Chintan Shivir at Vanijya Bhawan to discuss strategies for enhancing the country's medical device export ecosystem. The event, held in collaboration with the Department of Pharmaceuticals and the Export
Promotion Council for Medical Devices, aimed to address structural bottlenecks and improve global competitiveness in the MedTech sector. The theme of the event was 'Achieving 30@2030 - USD 30 Billion Market Size by 2030'. Over 150 participants, including policymakers, industry leaders, and regulators, attended the meeting to identify priority areas for manufacturing and export growth. Secretary of the Department of Commerce, Rajesh Agarwal, emphasized the need for India to transition from being known as the 'Pharmacy of the World' to a global MedTech manufacturing hub. Discussions focused on high-value manufacturing, research and development investments, and regulatory harmonization to achieve the USD 30 billion target by 2030.
Why It's Important?
The Chintan Shivir is significant as it highlights India's ambition to become a major player in the global MedTech industry. By focusing on increasing exports and improving manufacturing capabilities, India aims to enhance its economic growth and global market share. The initiative could lead to increased investment in research and development, fostering innovation and creating job opportunities within the country. Additionally, the emphasis on regulatory harmonization and quality production could improve the global perception of Indian medical devices, making them more competitive internationally. This move aligns with India's broader economic strategy to diversify its export portfolio and reduce dependency on traditional sectors.
What's Next?
Following the Chintan Shivir, the Department of Commerce plans to implement insights gained from the event to strengthen India's medical devices manufacturing ecosystem. This includes active engagement with the Department of Pharmaceuticals, the Central Drugs Standard Control Organisation, and the Export Promotion Council for Medical Devices. The focus will be on addressing structural issues, enhancing trade policy measures, and fostering collaboration between the government and private sector to scale domestic production and improve export competitiveness. Future steps may involve developing infrastructure, streamlining regulatory processes, and negotiating global trade deals to open new pathways for MedTech exports.
